The Influenza Virus B IgG ELISA is intended for the qualitative determination of IgG class antibodies against Influenza Virus B in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics.
- Assay Description:
- 1 hour incubation (37) + 30 min. (RT) + 15 min. (RT) = 1 hour, 45 min. total incubation time
- Catalog number:
- IB79879
- configuration:
- 96 Determinations, 12x8 removable strips
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- FDA exempt, can be used for in-vitro diagnostics
- MSDS:
- Please inquire
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Protocol:
- Sample types:
- Serum and Plasma (citrate, heparin)
- Sample volume:
- 100 µL of properly diluted (1:100) unknown / determination
- standards:
- Cut-off controls, ready to use
- storage:
- 2 - 8 °C
- sensitivity:
- Please see protocol for assay-specific performance characteristics
- Species:
- Human
